BCM
EXPO icon

Bayesian Capital Management’s Exponent EXPO Stock Holding History

Bayesian Capital Management’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,500
Closed -$904K – 790
2024
Q2 		$904K Buy
+9,500
New +$857K 0.1% 252
2019
Q4 		– Sell
-2,879
Closed -$201K – 644
2019
Q3 		$201K Buy
+2,879
New +$194K 0.04% 450
2017
Q1 		– Sell
-10,524
Closed -$317K – 497
2016
Q4 		$317K Buy
+10,524
New +$305K 0.08% 414

Other funds holding EXPO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bayesian Capital Management's EXPO Position: Q3 2024 in Review

Bayesian Capital Management sold out of Exponent (EXPO) in Q3 2024, closing a stake of 9,500 shares — an estimated $904K sold.

Bayesian Capital Management first reported a position in EXPO in Q4 2016 and held it in 3 quarters. The position peaked at $904K in Q2 2024. 373 funds tracked by Wall St. Rank hold EXPO as of Q3 2024.

  • Bayesian Capital Management reported no remaining Exponent position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 9,500 Exponent shares in Q3 2024, an estimated $904K.
  • Bayesian Capital Management first reported a position in Exponent in Q4 2016 and held it in 3 quarters.
  • Bayesian Capital Management's Exponent position peaked at $904K in Q2 2024.
  • 373 funds tracked by Wall St. Rank held Exponent as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.